Pricing
Login
Home
Charts
Search
Watchlist
Products

Gujarat Themis Biosyn Ltd

GUJTHEM
₹352.70-1.81%20 Nov 2026
Reports
Pharma API

Gujarat Themis Biosyn Ltd

GUJTHEM
₹352.70
-1.81%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹4,590Cr
Close
Close Price
₹352.70
Industry
Industry
Pharma API
PE
Price To Earnings
213.76
PS
Price To Sales
27.68
Revenue
Revenue
₹166Cr
Rev Gr TTM
Revenue Growth TTM
—
PAT Gr TTM
PAT Growth TTM
—

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterJun 2025Sep 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
3642444450
Growth YoY
Revenue Growth YoY%
22.117.9
Expenses
ExpensesCr
2221252351
Operating Profit
Operating ProfitCr
14211921-1
OPM
OPM%
38.849.543.847.5-1.8
Other Income
Other IncomeCr
01103
Interest Expense
Interest ExpenseCr
00228
Depreciation
DepreciationCr
23445
PBT
PBTCr
12191415-11
Tax
TaxCr
35343
PAT
PATCr
9141111-14
Growth YoY
PAT Growth YoY%
22.2-197.1
NPM
NPM%
25.333.724.625.3-27.7
EPS
EPS₹
0.81.31.01.0-1.2
QuarterJun 2025Sep 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
3642444450
Growth YoY
Revenue Growth YoY%
22.117.9
Expenses
ExpensesCr
2221252351
Operating Profit
Operating ProfitCr
14211921-1
OPM
OPM%
38.849.543.847.5-1.8
Other Income
Other IncomeCr
01103
Interest Expense
Interest ExpenseCr
00228
Depreciation
DepreciationCr
23445
PBT
PBTCr
12191415-11
Tax
TaxCr
35343
PAT
PATCr
9141111-14
Growth YoY
PAT Growth YoY%
22.2-197.1
NPM
NPM%
25.333.724.625.3-27.7
EPS
EPS₹
0.81.31.01.0-1.2

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2026
Revenue
RevenueCr
166
Growth
Revenue Growth%
Expenses
ExpensesCr
90
Operating Profit
Operating ProfitCr
76
OPM
OPM%
45.5
Other Income
Other IncomeCr
2
Interest Expense
Interest ExpenseCr
3
Depreciation
DepreciationCr
13
PBT
PBTCr
62
Tax
TaxCr
15
PAT
PATCr
47
Growth
PAT Growth%
NPM
NPM%
28.1
EPS
EPS₹
4.3
Financial YearMar 2026
Revenue
RevenueCr
166
Growth
Revenue Growth%
Expenses
ExpensesCr
90
Operating Profit
Operating ProfitCr
76
OPM
OPM%
45.5
Other Income
Other IncomeCr
2
Interest Expense
Interest ExpenseCr
3
Depreciation
DepreciationCr
13
PBT
PBTCr
62
Tax
TaxCr
15
PAT
PATCr
47
Growth
PAT Growth%
NPM
NPM%
28.1
EPS
EPS₹
4.3
Avg. ROCE
1 Year14%
3 Years-
5 Years-
TTM14%
CFO / EBITDA
1 Year65%
3 Years-
5 Years-
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2026
Equity Capital
Equity CapitalCr
11
Reserves
ReservesCr
277
Current Liabilities
Current LiabilitiesCr
79
Non Current Liabilities
Non Current LiabilitiesCr
137
Total Liabilities
Total LiabilitiesCr
503
Current Assets
Current AssetsCr
89
Non Current Assets
Non Current AssetsCr
415
Total Assets
Total AssetsCr
503
Financial YearMar 2026
Equity Capital
Equity CapitalCr
11
Reserves
ReservesCr
277
Current Liabilities
Current LiabilitiesCr
79
Non Current Liabilities
Non Current LiabilitiesCr
137
Total Liabilities
Total LiabilitiesCr
503
Current Assets
Current AssetsCr
89
Non Current Assets
Non Current AssetsCr
415
Total Assets
Total AssetsCr
503

Cash Flow

Consolidated
Standalone
Financial YearMar 2026
Operating Cash Flow
Operating Cash FlowCr
49
Investing Cash Flow
Investing Cash FlowCr
-172
Financing Cash Flow
Financing Cash FlowCr
115
Net Cash Flow
Net Cash FlowCr
-9
Free Cash Flow
Free Cash FlowCr
CFO To PAT
CFO To PAT%
104.5
CFO To EBITDA
CFO To EBITDA%
64.6
Financial YearMar 2026
Operating Cash Flow
Operating Cash FlowCr
49
Investing Cash Flow
Investing Cash FlowCr
-172
Financing Cash Flow
Financing Cash FlowCr
115
Net Cash Flow
Net Cash FlowCr
-9
Free Cash Flow
Free Cash FlowCr
CFO To PAT
CFO To PAT%
104.5
CFO To EBITDA
CFO To EBITDA%
64.6

Ratios

Consolidated
Standalone
Financial YearMar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,4784,590
Price To Earnings
Price To Earnings
53.1213.8
Price To Sales
Price To Sales
14.927.7
Price To Book
Price To Book
8.64.5
EV To EBITDA
EV To EBITDA
34.978.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
OPM
OPM%
45.545.5
NPM
NPM%
28.128.1
ROCE
ROCE%
14.514.5
ROE
ROE%
16.216.2
ROA
ROA%
9.39.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,4784,590
Price To Earnings
Price To Earnings
53.1213.8
Price To Sales
Price To Sales
14.927.7
Price To Book
Price To Book
8.64.5
EV To EBITDA
EV To EBITDA
34.978.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
OPM
OPM%
45.545.5
NPM
NPM%
28.128.1
ROCE
ROCE%
14.514.5
ROE
ROE%
16.216.2
ROA
ROA%
9.39.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr5,4044,9914,9404,5904,4324,4223,050
Close PriceClose₹184.12620.1590.15352.70473.25484.50628.25
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE26.6128.1826.28213.7637.3819.3482.02
Price To SalesPS1.965.682.1627.684.561.551.99
RevenueRevenueCr2,7518792,2861669712,8511,535
Revenue Growth TTMRev Gr TTM%26.8%23.0%30.2%13.0%15.1%27.3%
PAT Growth TTMPAT Gr TTM%75.4%-2.8%89.5%28.3%14.9%476.3%
Market CapitalizationMkt CapCr5,4044,9914,9404,5904,4324,4223,050
Close PriceClose₹184.12620.1590.15352.70473.25484.50628.25
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE26.6128.1826.28213.7637.3819.3482.02
Price To SalesPS1.965.682.1627.684.561.551.99
RevenueRevenueCr2,7518792,2861669712,8511,535
Revenue Growth TTMRev Gr TTM%26.8%23.0%30.2%13.0%15.1%27.3%
PAT Growth TTMPAT Gr TTM%75.4%-2.8%89.5%28.3%14.9%476.3%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Mar 26
ResultPPT
Transcript
Summary
Dec 25
ResultPPT
Transcript
Summary
Sep 25
ResultPPT
Transcript
Summary
Jun 25
ResultPPT
Transcript
Summary
Mar 25
ResultPPT
Transcript
Summary
Dec 24
ResultPPT
Transcript
Summary
Sep 24
ResultPPT
Transcript
Summary
Jun 24
ResultPPT
Transcript
Summary
Mar 24
ResultPPT
Transcript
Summary
Dec 23
ResultPPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
ResultPPT
Transcript
Summary
Sep 21
Jun 21
ResultPPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Mar 26
ResultPPT
Transcript
Summary
Dec 25
ResultPPT
Transcript
Summary
Sep 25
ResultPPT
Transcript
Summary
Jun 25
ResultPPT
Transcript
Summary
Mar 25
ResultPPT
Transcript
Summary
Dec 24
ResultPPT
Transcript
Summary
Sep 24
ResultPPT
Transcript
Summary
Jun 24
ResultPPT
Transcript
Summary
Mar 24
ResultPPT
Transcript
Summary
Dec 23
ResultPPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
ResultPPT
Transcript
Summary
Sep 21
Jun 21
ResultPPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Load More
Interviews